Other Species / Isoforms
  ADRB2 (hamster)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T68
FERLQTVTNYFITSL
2 0
ADRB2 (human) FERLQTVtNYFITSL T68-p
ADRB2 (mouse) FERLQTVTNYFIISL T68
ADRB2 (rat) FERLQTVTNYFITSL T68
ADRB2 (hamster) FERLQTVTNYFITSL T68
Y132-p
CVIAVDRyIAITSPF
Upstream
4 0
Kinase, in vitro:
  • INSR (human)
Treatment
  • isoproterenol
ADRB2 (human) CVIAVDRyFAITSPF Y132-p
ADRB2 (mouse) CVIAVDRYVAITSPF Y132
ADRB2 (rat) CVIAVDRYVAITSPF Y132
ADRB2 (hamster) CVIAVDRyIAITSPF Y132-p
Y141-p
AITSPFKyQSLLTKN
Upstream
4 0
Kinase, in vitro:
  • INSR (human)
Treatment
  • isoproterenol
ADRB2 (human) AITSPFKyQSLLTKN Y141-p
ADRB2 (mouse) AITSPFKYQSLLTKN Y141
ADRB2 (rat) AITSPFKYQSLLTKN Y141
ADRB2 (hamster) AITSPFKyQSLLTKN Y141-p
Y219
LVVMVFVYSRVFQVA
3 0
ADRB2 (human) LVIMVFVySRVFQEA Y219-p
ADRB2 (mouse) LVVMVFVYSRVFQVA Y219
ADRB2 (rat) LVVMVFVYSRVFQVA Y219
ADRB2 (hamster) LVVMVFVYSRVFQVA Y219
G246
RFHSPNLGQVEQDGR
1 15
ADRB2 (human) RFHVQNLsQVEQDGR S246-p
ADRB2 (mouse) RFHAQNLsQVEQDGR S246-p
ADRB2 (rat) RFHAQNLsQVEQDGR S246-p
ADRB2 (hamster) RFHSPNLGQVEQDGR G246
S261-p
SGHGLRRssKFCLKE
Upstream
Downstream
9 3
Effects on Modified Protein
  • receptor desensitization, altered
Treatment
  • alprostadil
  • phorbol_ester
  • racepinefrine
view more >
ADRB2 (human) TGHGLRRssKFcLKE S261-p
ADRB2 (mouse) SGHGLRRssKFCLKE S261-p
ADRB2 (rat) SGHGLRSSSKFCLKE S261
ADRB2 (hamster) SGHGLRRssKFCLKE S261-p
S262-p
GHGLRRssKFCLKEH
Upstream
Downstream
15 4
Effects on Modified Protein
  • receptor desensitization, altered
Treatment
  • alprostadil
  • phorbol_ester
  • racepinefrine
view more >
ADRB2 (human) GHGLRRssKFcLKEH S262-p
ADRB2 (mouse) GHGLRRssKFCLKEH S262-p
ADRB2 (rat) GHGLRSSSKFCLKEH S262
ADRB2 (hamster) GHGLRRssKFCLKEH S262-p
C265
LRRssKFCLKEHKAL
1 0
ADRB2 (human) LRRssKFcLKEHKAL C265-pa
ADRB2 (mouse) LRRssKFCLKEHKAL C265
ADRB2 (rat) LRSSSKFCLKEHKAL C265
ADRB2 (hamster) LRRssKFCLKEHKAL C265
Y308
NLIPKEVYILLNWLG
1 0
ADRB2 (human) NLIRKEVyILLNWIG Y308-p
ADRB2 (mouse) NLIPKEVYILLNWLG Y308
ADRB2 (rat) NLIPKEVYILLNWLG Y308
ADRB2 (hamster) NLIPKEVYILLNWLG Y308
Y326
SAFNPLIYCRSPDFR
3 0
ADRB2 (human) SGFNPLIyCRSPDFR Y326-p
ADRB2 (mouse) SAFNPLIyCRSPDFR Y326-p
ADRB2 (rat) SAFNPLIYCRSPDFR Y326
ADRB2 (hamster) SAFNPLIYCRSPDFR Y326
S345
ELLCLRRSSSKAyGN
11 2
ADRB2 (human) ELLCLRRssLKAyGN S345-p
ADRB2 (mouse) ELLCLRRssSKTYGN S345-p
ADRB2 (rat) ELLCLRRSSSKTYGN S345
ADRB2 (hamster) ELLCLRRSSSKAyGN S345
S346
LLCLRRSSSKAyGNG
12 3
ADRB2 (human) LLCLRRssLKAyGNG S346-p
ADRB2 (mouse) LLCLRRssSKTYGNG S346-p
ADRB2 (rat) LLCLRRSSSKTYGNG S346
ADRB2 (hamster) LLCLRRSSSKAyGNG S346
Y350-p
RRSSSKAyGNGySSN
Upstream
Downstream
8 0
Effects on Modified Protein
  • molecular association, regulation
  • receptor desensitization, altered
Kinase, in vitro:
  • INSR (human)
Treatment
  • insulin
  • isoproterenol
ADRB2 (human) RRssLKAyGNGyssN Y350-p
ADRB2 (mouse) RRssSKTYGNGYssN Y350
ADRB2 (rat) RRSSSKTYGNGYSSN Y350
ADRB2 (hamster) RRSSSKAyGNGySSN Y350-p
Y354-p
SKAyGNGySSNSNGK
Upstream
5 0
Kinase, in vitro:
  • INSR (human)
Treatment
  • insulin
  • isoproterenol
ADRB2 (human) LKAyGNGyssNGNtG Y354-p
ADRB2 (mouse) SKTYGNGYssNSNGR Y354
ADRB2 (rat) SKTYGNGYSSNSNGR Y354
ADRB2 (hamster) SKAyGNGySSNSNGK Y354-p
S355
KAyGNGySSNSNGKT
27 2
ADRB2 (human) KAyGNGyssNGNtGE S355-p
ADRB2 (mouse) KTYGNGYssNSNGRT S355-p
ADRB2 (rat) KTYGNGYSSNSNGRT S355
ADRB2 (hamster) KAyGNGySSNSNGKT S355
S356
AyGNGySSNSNGKTD
27 2
ADRB2 (human) AyGNGyssNGNtGEQ S356-p
ADRB2 (mouse) TYGNGYssNSNGRTD S356-p
ADRB2 (rat) TYGNGYSSNSNGRTD S356
ADRB2 (hamster) AyGNGySSNSNGKTD S356
Y364-p
NSNGKTDyMGEASGC
Upstream
Downstream
5 0
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • INSR (human)
Putative in vivo kinases:
  • INSR (human)
Treatment
  • insulin
  • isoproterenol
ADRB2 (human) gap -
ADRB2 (mouse) NSNGRTDYTGEPNTC Y364
ADRB2 (rat) NSNGRTDYTGEQSAY Y364
ADRB2 (hamster) NSNGKTDyMGEASGC Y364-p
M365
SNGKTDyMGEASGCQ
3 0
ADRB2 (human) GyssNGNtGEQsGYH T360-p
ADRB2 (mouse) SNGRTDYTGEPNTCQ T365
ADRB2 (rat) SNGRTDYTGEQSAYQ T365
ADRB2 (hamster) SNGKTDyMGEASGCQ M365
S369
TDyMGEASGCQLGQE
5 0
ADRB2 (human) NGNtGEQsGYHVEQE S364-p
ADRB2 (mouse) TDYTGEPNTCQLGQE N369
ADRB2 (rat) TDYTGEQSAYQLGQE S369
ADRB2 (hamster) TDyMGEASGCQLGQE S369
T389
LCEDPPGTESFVNCQ
4 0
ADRB2 (human) LCEDLPGtEDFVGHQ T384-p
ADRB2 (mouse) LCEDPPGMEGFVNCQ M389
ADRB2 (rat) LCEEAPGMEGFVNCQ M389
ADRB2 (hamster) LCEDPPGTESFVNCQ T389
T398
SFVNCQGTVPSLSLD
3 0
ADRB2 (human) DFVGHQGtVPsDNID T393-p
ADRB2 (mouse) GFVNCQGTVPSLSVD T398
ADRB2 (rat) GFVNCQGTVPSLSID T398
ADRB2 (hamster) SFVNCQGTVPSLSLD T398
S401
NCQGTVPSLSLDSQG
4 1
ADRB2 (human) GHQGtVPsDNIDsQG S396-p
ADRB2 (mouse) NCQGTVPSLSVDSQG S401
ADRB2 (rat) NCQGTVPSLSIDSQG S401
ADRB2 (hamster) NCQGTVPSLSLDSQG S401
S406
VPSLSLDSQGRNCST
3 0
ADRB2 (human) VPsDNIDsQGRNCst S401-p
ADRB2 (mouse) VPSLSVDSQGRNCST S406
ADRB2 (rat) VPSLSIDSQGRNCNT S406
ADRB2 (hamster) VPSLSLDSQGRNCST S406
S412
DSQGRNCSTNDSPL_
4 1
ADRB2 (human) DsQGRNCstNDsLL_ S407-p
ADRB2 (mouse) DSQGRNCSTNDSPL_ S412
ADRB2 (rat) DSQGRNCNTNDSPL_ N412
ADRB2 (hamster) DSQGRNCSTNDSPL_ S412
T413
SQGRNCSTNDSPL__
1 0
ADRB2 (human) sQGRNCstNDsLL__ T408-p
ADRB2 (mouse) SQGRNCSTNDSPL__ T413
ADRB2 (rat) SQGRNCNTNDSPL__ T413
ADRB2 (hamster) SQGRNCSTNDSPL__ T413
S416
RNCSTNDSPL_____
5 1
ADRB2 (human) RNCstNDsLL_____ S411-p
ADRB2 (mouse) RNCSTNDSPL_____ S416
ADRB2 (rat) RNCNTNDSPL_____ S416
ADRB2 (hamster) RNCSTNDSPL_____ S416